Novel glycyrrhetinic acid conjugated pH-sensitive liposomes for the delivery of doxorubicin and its antitumor activities-Reference-Cited by-同舟云学术

Novel glycyrrhetinic acid conjugated pH-sensitive liposomes for the delivery of doxorubicin and its antitumor activities

Published:2016 Issue:22 Volume:6 Page:17782-17791
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Chen Qing¹²³⁴,Ding Huaiwei⁵²⁴,Zhou Jinxing¹²³⁴,Zhao Xiufeng⁶⁷⁴,Zhang Jiulong¹²³⁴,Yang Chunrong⁸⁹⁴,Li Kexin¹²³⁴,Qiao Mingxi¹²³⁴,Hu Haiyang¹²³⁴,Ding Pingtian¹²³⁴,Zhao Xiuli¹²³⁴

Affiliation:

1. School of Pharmacy

2. Shenyang Pharmaceutical University

3. Shenyang

4. P.R. China

5. School of Pharmaceutical Engineering

6. Hongqi Hospital of Mudanjiang Medical University

7. Mudanjiang

8. College Pharmacy of Jiamusi University

9. Jiamusi

Abstract

A novel pH-sensitive conjugate glycyrrhetinic acid–polyethylene glycol–Schiff bond–cholesterol (GPSC) has been synthesized successfully and used to construct doxorubicin-loaded liposomes with both pH-sensitive features and active targeting ability.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2016/RA/C6RA01580H

Reference47 articles.

1. Primary liver cancer deaths and related years of life lost attributable to hepatitis B and C viruses in India

2. Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world setting

3. Second Cancers and Richter Transformation Are the Leading Causes of Death in Patients With Trisomy 12 Chronic Lymphocytic Leukemia